GreyBrook logotype
Investor Login Contact Us

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

December 31, 2021

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres across the U.S. The company has provided nearly 1,000,000 treatments changing the lives of more than 20,000 patients and has achieved phenomenal growth over the past year through clinic acquisitions, and expansions into new therapies and treatment methods.

Greenbrook TMS was founded with the belief that mental health care as it then existed was failing too many people. Only 49% of patients respond to their first-round antidepressant medication. The other 51% endured lengthy cycles of medication trial-and-error with little improvement, often experiencing side effects like weight gain and sexual dysfunction which worsened their depression symptoms. We knew there had to be a better way.

In 2011, Greenbrook TMS opened its first location in Tysons Corner, Virginia, with a vision to bring together the best care teams and technology into a more personalized, more accessible, and most importantly more effective treatment experience.

Today, more than 10 years after launching that first centre, Greenbrook has provided nearly 1,000,000 treatments and changed the lives of more than 20,000 patients. “We have the largest clinical data set in the U.S., and our TMS patients experience a 62% response rate which is well above the current antidepressant medication therapy rates and that is for patients who have already failed other treatments”, explained Bill Leonard, CEO Greenbrook TMS. “Many of our patients achieve full remission from their depression symptoms—all with little to no side effects”.  With more than 40% growth since 2015, Greenbrook’s 149 centers span 17 states; each location offers state-of-the-art treatment technology in a soothing, spa-like environment, bringing the Greenbrook care experience to more communities. In early 2021, to complement Greenbrook’s deep expertise in depression treatment, the company piloted offering Spravato, a nasal esketamine spray that is FDA-approved for treatment resistant major depressive disorder.

“Our passion has always been fueled by the goal of changing patient’s lives for the better. Looking ahead, as the pandemic continues to disrupt all aspects of daily life, rates of depression continue to soar and the importance of and need for our work is greater than ever. To help meet treatment needs in the community, and building on our successes in 2021, we will expand our Spravato offering to 23 locations by the end of Q1 2022”.

“We are very proud of what the Greenbrook team has accomplished and their commitment to helping so many people. As we expand Greenbrook’s clinical footprint, we are excited to see the impact that TMS and other innovative therapies can have on the lives of patients struggling with mental health”, Elias Vamvakas, Chairman Greenbrook TMS and Chairman Greybrook Capital.

To learn more about Greenbrook TMS, visit


Latest Insights

The Elser Hotel & Residences Miami Successfully Closes on $80M in Sales in Less Than 60 Days

January 20, 2023

Greybrook and PMG are pleased to announce The Elser Hotel & Residences Miami, a 49-story new construction luxury condominium located at 398 NE 5th St., has successfully closed on $80 million in sales in less than 60 days. This immense…

Emerald Crossing Welcomes First Wave of Homeowners

January 20, 2023

Homes in the first phase of the development will continue to close throughout 2023. This development is divided into two phases, 138 homes in Phase 1 and 119 homes in Phase 2, including 70 premium lots that back onto protected…

Waterside Villas in Whitby Nears Completion

January 15, 2023

Construction has progressed on the remaining blocks of townhomes in the development with only one block of townhomes left to be completed. Home closings began in Q2 2022, with the final closings slated for the end of Q1 2023. Located…

Greybrook Invests $41,545,000 in a High-Rise Residential Development Project with Tribute Communities in Whitby, Ontario

Portfolio Updates
January 13, 2023

Greybrook Realty Partners Inc. announced today the successful closing of an equity investment by its managed issuer of $41,545,000 to acquire and oversee the development of a parcel of land located on the west side of Charles Street between Victoria…

Watch Greybrook’s 2022 Sizzle Reel – A Year of Milestones

January 12, 2023

Watch our 2022 Sizzle Reel Over the past year, we invested in our 100th real estate project and surpassed $2 billion of equity capital deployed. Having achieved these major milestones, our portfolio is now valued at over CAD$30 billion of…

The Regional Municipality of Durham – A Region on the Rise

November 30, 2022

Greybrook has been investing in the growing region since 2017 and is continuing to actively evaluate both low-rise and high-rise investment opportunities to meet the needs of Durham Region’s growing population. Click here to view Greybrook’s portfolio in Durham Region…

An Inside Look at The Elser Hotel & Residences Miami

November 29, 2022

On November 17th the Development Team celebrated the official launch with a ribbon-cutting ceremony that also marked the launch of the hotel component at The Elser alongside our partner, PMG, and industry leading hospitality management company, Highgate. The hotel welcomed…

Construction Progress Continues at 181 East in Toronto

November 28, 2022

With excavation now complete and the first of two cranes erected, the construction team is now pouring the ground floor on the western portion of the site and expects to have the underground garage fully formed up to grade in…

Greybrook CEO Peter Politis Featured Guest on the CashFlow Pro Podcast

November 21, 2022

Watch the episode below. In the episode titled “Real Estate Investing in Development”, Peter discusses Greybrook’s Society Living platform to an engaged audience of hands-on real estate investors. He shares the unique selling proposition of this national platform – affordable…

Velo Blu Pedal for Blu Genes Charity Ride Raises Over $430,000

November 15, 2022

Watch the 2022 Velo Blu Highlight Video What started as a personal mission to find a cure for a rare and fatal genetic disorder called Tay-Sachs disease soon became a larger vision of raising funds and awareness to advance gene…

[geot_filter exclude_country="cn"]All Publications[/geot_filter][geot_filter country="cn"]所有出版物[/geot_filter]

Join our newsletter and keep up to date with our news & insights

Contact us